NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- LifeSci Partners, a life science focused consultancy, announced today the launch of LifeSci Events, which supports life sciences companies with turnkey ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease ...

NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and ...

SEATTLE, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...

NASHUA, N.H., Jan. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will ...

MIAMI, Dec. 18, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today ...

CEO to participate in a panel discussion on the topic of “Psychedelics: More Than Just a Trip” – January 5, 2022 at 10:00 am ET / 3:00 pm GMT Cosmo Feilding Mellen, CEO of Beckley Psytech, will ...

Mont-Saint Guibert, Belgium, 29 July, 2020: Novadip Biosciences (“Novadip” or “the Company”), a clinical-stage biopharmaceutical company leveraging its unique tissue regeneration technology platform ...